These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 16428155
1. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. Singal A, Pandhi D, Agrawal S, Das S. J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155 [Abstract] [Full Text] [Related]
2. Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis. Ramam M, Prasad HR, Manchanda Y, Khaitan BK, Banerjee U, Mukhopadhyaya A, Shetty R, Gogtay JA. Indian J Dermatol Venereol Leprol; 2003; 69(2):154-8. PubMed ID: 17642865 [Abstract] [Full Text] [Related]
8. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. Parish LC, Parish JL, Routh HB, Avakian E, Olayinka B, Pappert EJ, Plaum S, Fleischer AB, Hardas B. J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664 [Abstract] [Full Text] [Related]
9. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lowe N, Lucky A, Reyes B, Stewart D, Willis I. J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200 [Abstract] [Full Text] [Related]
11. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. Lesher JL, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, Weintraub JS. J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S20-4. PubMed ID: 9039201 [Abstract] [Full Text] [Related]
12. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Faergemann J, Mörk NJ, Haglund A, Odegård T. Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961 [Abstract] [Full Text] [Related]
15. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial. Schopf R, Hettler O, Bräutigam M, Weidinger G, Kaben U, Mayser P, Resl V. Mycoses; 1999 Apr; 42(5-6):415-20. PubMed ID: 10536434 [Abstract] [Full Text] [Related]
17. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E. J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050 [Abstract] [Full Text] [Related]
18. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. Tschen E, Elewski B, Gorsulowsky DC, Pariser DM. J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199 [Abstract] [Full Text] [Related]
19. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris. Bogaert H, Cordero C, Ollague W, Savin RC, Shalita AR, Zaias N. J Int Med Res; 1986 Feb; 14(4):210-6. PubMed ID: 3530834 [Abstract] [Full Text] [Related]